Clinical Study
Retinoblastoma in the Democratic Republic of Congo: 20-Year Review from a Tertiary Hospital in Kinshasa
Table 3
Regimens, courses, duration, and followup of chemotherapy for retinoblastoma over time.
| Regimen | Years | n | Mean of chemotherapy courses (ranges) | Followup from start of treatment (months) |
| C/wk | 1995–1990 | 8 | 3.6 (2–6) | 1 | VC-enu-VC | 1991 | 1 | 12 | 9 | VC/wk | 1991–1996 | 8 | 5.5 (5–6) | 3 | VC-Prednisolone | 1992 | 1 | 1 | 21 days | VC-VAC+M | 1996 | 2 | 24.5 (6-43) | 10 | VAC+M/3 wks | 1997–2000 | 4 | 5.25 (1–12) | 5 | VAC/3 wks | 1998–2005 | 14 | 3.1 (1–6) | 6 | VMC-VAC-enu- | 2003 | 1 | 16 | 15 | VAC+VMC/3 wk | 2004 | 1 | 1 | 13 |
|
|
C: cyclophosphamide; V: vincristine; A: Adriamycine; M: methotrexate; enu: enucleation.
|